Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Tomoaki Hasui"'
Autor:
Takafumi Yukawa, Tohru Yamashita, Toshihiro Imaeda, Hiroyuki Kakei, Shogo Hashizume, Minoru Nakamura, Masaki Daini, Atsutoshi Okabe, Kosuke Nakashima, Akina Harada, Naohiro Narita, Ezio Bettini, Annarosa Ugolini, Mauro Corsi, Tomoaki Hasui
Publikováno v:
Bioorganic & Medicinal Chemistry. 79:117150
Autor:
Fumie Sakurai, Takafumi Yukawa, Asato Kina, Masataka Murakami, Kazuaki Takami, Sachie Morimoto, Masaki Seto, Makoto Kamata, Tohru Yamashita, Kosuke Nakashima, Naohiro Narita, Ezio Bettini, Annarosa Ugolini, Mauro Corsi, Tomoaki Hasui
Publikováno v:
Bioorganicmedicinal chemistry. 56
N-Methyl-d-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family and play a crucial role in learning and memory by regulating synaptic plasticity. Activation of NMDARs containing GluN2A, one of the NMDAR subunits, has r
Autor:
Imamura Keisuke, Tomoaki Hasui, Y. Hiura, Kumar Singh Saikatendu, Ikuo Fujimori, Morio Murakami, Takeshi Wakabayashi, Tsuyoshi Ishii, Hua Zou, J.D. Lawson, S.W. Lane, Y. Kikko, Masaomi Miyamoto, Hiroshi Imoto, A. Nakatani, M. Kasahara, Youichi Kawakita, Takeshi Kato, Makoto Fushimi
Publikováno v:
Journal of Medicinal Chemistry. 62:4915-4935
Anaplastic lymphoma kinase (ALK), a member of the receptor tyrosine kinase family, is predominantly expressed in the brain and implicated in neuronal development and cognition. However, the detailed function of ALK in the central nervous system (CNS)
Autor:
Tomoaki Hasui, Nahid Amini, Takanobu Kuroita, Christer Halldin, Ryuji Nakao, Vladimir Stepanov, Akihiro Takano, Shotaro Miura, Kosuke Nakashima, Takahiko Taniguchi, Haruhide Kimura
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 58:202-208
Phosphodiesterase 10A (PDE10A) is a member of the PDE family of enzymes that degrades cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Our aim was to label a series of structurally related PDE10A inhibitors with carbon
Autor:
Akina Harada, Kazunori Suzuki, Naomi Kamiguchi, Haruhide Kimura, Christer Halldin, Tomoaki Hasui, Shotaro Miura, Akihiro Takano, Takahiko Taniguchi, Vladimir Stepanov, Tsuyoshi Ishii, Takanobu Kuroita
Publikováno v:
Nuclear Medicine and Biology. 42:146-154
Introduction Phosphodiesterase 10A (PDE10A) is a dual-substrate PDE that hydrolyzes both cAMP and cGMP and is selectively expressed in striatal medium spiny neurons. Recent studies have suggested that PDE10A inhibition is a novel approach for the tre
Autor:
Tomoaki Hasui, Christer Halldin, Nahid Amini, Ryuji Nakao, Takahiko Taniguchi, Akihiro Takano, Vladimir Stepanov, Shotaro Miura, Haruhide Kimura
Publikováno v:
Nuclear medicine and biology. 57
Introduction Phosphodiesterase 10A (PDE10A) is a member of the PDE enzyme family that degrades cyclic adenosine and guanosine monophosphates (cAMP and cGMP). Based on the successful development of [ 11 C]T-773 as PDE10A positron emission tomography (
Autor:
Tomoaki Hasui, Boyd Steven A, Shoji Fukumoto, Cassandra Gauthier, Satoshi Endo, Hideki Matsui, Tony Pisal Tang, Christopher Stephen Siedem, Sachiko Shiotani, Atsushi Mizukami, Kouhei Asano, Koji Fuji, Taiichi Ohra, Nobuhiro Nishigaki, Keiji Kusumoto, Jun Fujimoto, Takahiro Sugimoto, Midori Ono, Satoshi Sogabe, Masato Oosawa, Lisa A. De Meese, Norio Ohyabu, Noriyuki Habuka
Publikováno v:
Bioorganic & Medicinal Chemistry. 22:5428-5445
In the course of our study on selective nonsteroidal mineralocorticoid receptor (MR) antagonists, a series of novel benzoxazine derivatives possessing an azole ring as the core scaffold was designed for the purpose of attenuating the partial agonisti
Autor:
Lisa A. De Meese, Hideki Matsui, Tomoaki Hasui, Norio Ohyabu, Noriyuki Habuka, Cassandra Gauthier, Boyd Steven Armen, Taiichi Ohra, Satoshi Endo, Shoji Fukumoto, Satoshi Sogabe, Atsushi Mizukami, Kouhei Asano, Tony Pisal Tang, Christopher Stephen Siedem
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:5983-5994
Dihydrofuran-2-one and dihydropyrrol-2-one derivatives were identified as novel, potent and selective mineralocorticoid receptor (MR) antagonists by the structure-based drug design approach utilizing the crystal structure of MR/compound complex. Intr
Autor:
Hideyuki Oki, Takahiko Taniguchi, Tomoaki Hasui, Makoto Fushimi, Masato Yoshikawa, Hironori Kokubo, Jun Kunitomo, Takenori Hitaka, Kosuke Nakashima
Publikováno v:
Bioorganicmedicinal chemistry. 24(16)
Utilizing structure-based drug design techniques, we designed and synthesized phosphodiesterase 10A (PDE10A) inhibitors based on pyridazin-4(1H)-one. These compounds can interact with Tyr683 in the PDE10A selectivity pocket. Pyridazin-4(1H)-one deriv
Publikováno v:
European Journal of Organic Chemistry. 2009:1148-1151
Mannich-type reactions of aldehydes with secondary amines and a ketene silyl acetal were promoted by trimethoxyborane in DMSO to afford the corresponding β-amino esters in good yields. B(OMe)3 also promoted Ugi-type reactions ofaldehydes with second